Sino Biopharmaceutical Limited (SBMFF) EV/EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | 0.44 | -0.44 | -0.22 | 0.37 | 1.18 | -1.37 | ||
| Changes by years, y/y, % | -85% | -199% | -50% | -269% | +218% | -16.2% | |||
Sino Biopharmaceutical Limited. EV/EBITDA
Sino Biopharmaceutical Limited. EV/EBITDA, changes, %
Sino Biopharmaceutical Limited (SBMFF) EV/EBITDA US GAAP (quarter values) |
||||||||
| FY2024Q3 | FY2024Q4 | FY2025Q1 | FY2025Q2 | FY2025Q4 | LTM ? | |||
| EV/EBITDA | ? | 0.48 | 0.37 | 0.05 | 0.76 | -1.13 | -1.37 | |
| Changes by years, y/y, % | -307% | -254% | -110% | -264% | -404% | |||
| Changes by quarters, q/q, % | -204% | -23% | -86% | +1 366% | -249% | |||